Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Vascular pharmacology

• Publication date

  2022-02-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vph.2022.106969PMID 35149209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin.

  2020cited by this paper
• Preventing and Treating Anthracycline Cardiotoxicity: New Insights.

  2020cited by this paper
• Olive Leaves and Hibiscus Flowers Extracts-Based Preparation Protect Brain from Oxidative Stress-Induced Injury

  2020cited by this paper
• Hydrogen sulfide and vascular regulation – An update

  2020cited by this paper
• Apoptotic-Induced Effects of Acacia Catechu Willd. Extract in Human Colon Cancer Cells

  2020cited by this paper
• Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: A review.

  2020cited by this paper
• Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death

  2019cited by this paper
• The multi-factorial nature of clinical multidrug resistance in cancer.

  2019cited by this paper
• Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.

  2019cited by this paper
• Hydrogen sulfide inhibited L-type calcium channels (CaV1.2) via up-regulation of the channel sulfhydration in vascular smooth muscle cells.

  2019cited by this paper
• Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma

  2018cited by this paper
• New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations

  2018cited by this paper
• Molecular mechanism of doxorubicin‐induced cardiomyopathy – An update

  2018cited by this paper
• Role of Endothelium in Doxorubicin-Induced Cardiomyopathy

  2018cited by this paper
• In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies.

  2017cited by this paper
• Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.

  2017cited by this paper
• MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood–brain Barrier: In Vitro Cardiovascular Safety Evaluation

  2017cited by this paper
• In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents

  2016cited by this paper
• Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies

  2016cited by this paper
• H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.

  2016cited by this paper
• Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression

  2012cited by this paper
• Capture and visualization of hydrogen sulfide by a fluorescent probe.

  2011cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.

  2009cited by this paper
• Doxorubicin-induced vasomotion and [Ca2+]i elevation in vascular smooth muscle cells from C57BL/6 mice

  2009cited by this paper
• Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells

  2007cited by this paper
• Hydrogen sulfide‐induced apoptosis of human aorta smooth muscle cells via the activation of mitogen‐activated protein kinases and caspase‐3

  2004cited by this paper
• Hydrogen sulfide induces serum‐independent cell cycle entry in nontransformed rat intestinal epithelial cells

  2003cited by this paper
• Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes

  2002cited by this paper
• Chronic vascular toxicity of doxorubicin in an organ‐cultured artery

  2001cited by this paper
• Four deaths and a funeral: from caspases to alternative mechanisms

  2001cited by this paper
• Doxorubicin-induced Apoptosis in Endothelial Cells and Cardiomyocytes Is Ameliorated by Nitrone Spin Traps and Ebselen

  2000cited by this paper
• Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.

  2000cited by this paper
• On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings.

  2000cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998cited by this paper

• A "drug-carrier homologation" cardiac patch for myocardial infarction therapy via month-long controlled H2S release.

  2025cites this paper
• Low Molecular Weight Modifications of Anthracycline Antibiotics. Part II. Reactions by Other Positions (A Review)

  2024cites this paper
• H2S Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity

  2023cites this paper
• In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists.

  2023cites this paper
• Hydrogen sulfide: Recent development of its dual donors and hybrid drugs

  2023cites this paper
• Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells

  2022cites this paper